prognostic marker


Also found in: Dictionary, Thesaurus, Legal, Financial, Encyclopedia.

prognostic marker

Any finding or characteristic that indicates that a disease is likely to improve, remit, or relapse.
See also: marker
References in periodicals archive ?
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.
Known prognostic markers, such as grade, could be ascribed to the noted, attenuated, androgen signaling signature seen in high-grade cancer (Gleason pattern 4), similar to metastatic PCa, which may reflect dedifferentiation and explain the clinical association of grade and prognosis.
The search for meaningful prognostic markers in diffuse large B cell lymphoma.
Because of the possible role of ATM as a biomarker of therapeutic radiation sensitivity, (25-27) we evaluated whether ATM expression was a prognostic marker in PCNS DLBCL patients with adjuvant chemotherapy and radiotherapy.
Narla will work with the breast cancer team, led by Lyndsay Harris, MD, to study further KLF6-SV1's potential as a prognostic marker for patients with poor outcomes.
DNA methylation in serum of breast cancer patients: an independent prognostic marker.
In what they described as the first study to show that erythropoietin levels are a prognostic marker in CHF, the investigators assessed erythropoietin and hemoglobin levels in 74 patients with stable mild to advanced chronic heart failure.
p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
We describe the validation of a new standardized quantitative real-time reverse transcription-PCR (qPCR) analysis for measuring ZAP70 mRNA in purified B lymphocytes and its power as both a surrogate for IGHV mutational status and a prognostic marker for survival and treatment-free time in CLL.
Cardiac troponin I levels, which are often elevated in patients who have either viral or idiopathic pericarditis, cannot be used as a prognostic marker in these conditions as they are in acute coronary syndromes, reported Dr.
Mutated MLL genes are viewed as a bad prognostic marker, Cleary said.
The poster entitled "Guanylyl Cyclase C (GCC) Lymph Nodes (LN) Classification as a Prognostic Marker in Patients with Stage II Colon Cancer: A Pooled Analysis" confirms prognostic capabilities of the Previstage test in patients with colon cancer.